HSS Journal

, Volume 6, Issue 1, pp 102–107

Hepatitis C- and Human Immunodeficiency Virus-Induced Hypersensitivity Vasculitis

A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery
  • Roodabeh Michelle Koolaee
  • Ora Singer
  • Anne Bass
  • Robert Winchester
  • Surya Seshan
  • Doruk Erkan
Clinical Pathology Conference
  • 63 Downloads

Keywords

hypersensitivity vasculitis hepatitis C HIV 

References

  1. 1.
    Sene D, Ghillani-Dalbin P, Thibault V et al (2004) Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J. Rheumatol. 31:2199–2206PubMedGoogle Scholar
  2. 2.
    Vallat L, Benhamou Y, Gutierrez M et al (2004) Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum. 50:3668–3678CrossRefPubMedGoogle Scholar
  3. 3.
    Sano S, Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL et al (1994) Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N. Engl. J. Med. 330:751–756CrossRefGoogle Scholar
  4. 4.
    Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R et al (1993) Interferon-alfa in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 81:1132–1136PubMedGoogle Scholar
  5. 5.
    Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, DelVecchio S et al (1997) Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90:3865–3873PubMedGoogle Scholar
  6. 6.
    Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P et al (2002) Interferon-alfa and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 46:3317–3326CrossRefPubMedGoogle Scholar
  7. 7.
    Naarendorp M, Kallemuchikkal U, Nuovo GJ, Gorevic PD (2001) Longterm efficacy of interferon-alfa for extrahepatic disease associated with hepatitis C virus infection. J. Rheumatol. 28:2466–2473PubMedGoogle Scholar
  8. 8.
    Saadoun D, Resche-Rigon M, Thibault V et al (2006) Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a longterm followup study. Arthritis Rheum. 54:3696–3706CrossRefPubMedGoogle Scholar
  9. 9.
    Fain O, Hamidou M, Cacoub P (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum. 57:1473–1480CrossRefPubMedGoogle Scholar
  10. 10.
    Hearth-Holmes M, Zahradka S, Baethge BA et al (1991) Leukocytoclastic vasculitis associated with hepatitis C. Am. J. Med. 90(6):765–766CrossRefPubMedGoogle Scholar
  11. 11.
    Yazici Y, Lockshin MD (2006) The vasculitides. In: Paget S (ed) Hospital for Special Surgery Manual of Rheumatology and Outpatient Orthopedic Disorders. New York, LippincottGoogle Scholar
  12. 12.
    Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum. 33(8):1108–1113PubMedGoogle Scholar
  13. 13.
    Cacoub P, Poynard T, Ghillani P et al (1999) Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C. Arthritis Rheum. 42:2204–2212CrossRefPubMedGoogle Scholar
  14. 14.
    Osborne SF, Stafford L, Orr KG (2002) Paroxetine-associated psoriasis. Am. J. Psychiatr. 159(12):2113CrossRefPubMedGoogle Scholar
  15. 15.
    Brenner S, Cabili S, Wolf R (1993) Widespread erythematous scaly plaques in an adult. Psoriasiform eruption induced by quinidine. Arch. Dermatol. 129(10):1331–1332 1334–5CrossRefPubMedGoogle Scholar
  16. 16.
    Sfikakis PP, Iliopoulos A, Elezoglou A et al (2005) Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 52(8):2513–2518CrossRefPubMedGoogle Scholar
  17. 17.
    Collamer AN, Guerrero KT, Henning JS et al (2008) Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 59(7):996–1001 ReviewCrossRefPubMedGoogle Scholar
  18. 18.
    Taylor W, Gladman D, Marchesoni A et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 54(8):2665–2673CrossRefPubMedGoogle Scholar
  19. 19.
    Reich K, Hüffmeier U, König IR et al (2007) TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-875 independent of the PSORS1 risk allele. Arthritis Rheum. 56:2056–2064CrossRefPubMedGoogle Scholar
  20. 20.
    Cargill M, Schrodi SJ, Chang M et al (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80:273–290CrossRefPubMedGoogle Scholar
  21. 21.
    McHugh NJ, Laurent MR, Treadwell BL et al (1987) Psoriatic arthritis: clinical subgroups and histocompatibility antigens. Ann. Rheum. Dis. 46(13):84–88Google Scholar
  22. 22.
    Queiro R, Gonzalez S, Lopez-Larrea C et al (2006) HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis. Arthritis Res. Ther. 8(6):R185CrossRefPubMedGoogle Scholar
  23. 23.
    Schröder JM, Reich K, Kabashima K et al (2006) Who is really in control of skin immunity under physiological circumstances—lymphocytes, dendritic cells or keratinocytes? Exp. Dermatol. 15:913–929PubMedGoogle Scholar
  24. 24.
    Sano S, Chan KS, Carbajal S et al (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11:43–49CrossRefPubMedGoogle Scholar

Copyright information

© Hospital for Special Surgery 2009

Authors and Affiliations

  • Roodabeh Michelle Koolaee
    • 4
  • Ora Singer
    • 1
  • Anne Bass
    • 1
  • Robert Winchester
    • 2
  • Surya Seshan
    • 3
  • Doruk Erkan
    • 1
  1. 1.Department of RheumatologyHospital for Special SurgeryNew YorkUSA
  2. 2.Department of RheumatologyColumbia University New York Presbyterian HospitalNew YorkUSA
  3. 3.Department of PathologyWeill-Cornell New York Presbyterian HospitalNew YorkUSA
  4. 4.Department of Internal MedicineSt. Luke’s–Roosevelt Hospital CenterNew YorkUSA

Personalised recommendations